Literature DB >> 16710552

A human rights approach to the WHO Model List of Essential Medicines.

Xavier Seuba1.   

Abstract

Since the first WHO Model List of Essential Medicines was adopted in 1977, it has become a popular tool among health professionals and Member States. WHO's joint effort with the United Nations Committee on Economic, Social and Cultural Rights has resulted in the inclusion of access to essential medicines in the core content of the right to health. The Committee states that the right to health contains a series of elements, such as availability, accessibility, acceptability and quality of health goods, services and programmes, which are in line with the WHO statement that essential medicines are intended to be available within the context of health systems in adequate amounts at all times, in the appropriate dosage forms, with assured quality and information, and at a price that the individual and the community can afford. The author considers another perspective by looking at the obligations to respect, protect and fulfil the right to health undertaken by the states adhering to the International Covenant of Economic, Social and Cultural Rights (ICESCR) and explores the relationship between access to medicines, the protection of intellectual property, and human rights.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16710552      PMCID: PMC2627340          DOI: 10.2471/blt.04.019133

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  WHO Essential Medicines List for Children: impact on patient outcomes?

Authors:  Andy Gray
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

2.  'Issues of equity are also issues of rights': lessons from experiences in Southern Africa.

Authors:  Leslie London
Journal:  BMC Public Health       Date:  2007-01-26       Impact factor: 3.295

3.  Trends in the utilization of antihypertensive medications among Palestine refugees in Jordan, 2008-2012.

Authors:  Rawan Saadeh; Dima Qato; Ali Khader; Yousef Shahin; Akihiro Seita
Journal:  J Pharm Policy Pract       Date:  2015-05-18

4.  Trends analysis for drug utilization in county public hospitals: a sample study of the pilot area of health care reform in China.

Authors:  Xuefeng Xie; Xu Jin; Ling Zhang; Huihui Sun; Aizong Shen; Xiaohui Huang; Yehuan Sun
Journal:  BMC Health Serv Res       Date:  2018-10-23       Impact factor: 2.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.